Neurobiological Technologies (Neurobiological Technologies) Liabilities-to-Assets : 0.02 (As of Sep. 2009)

Neurobiological Technologies Liabilities-to-Assets Chart

Neurobiological Technologies Annual Data
	Trend	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09
Liabilities-to-Assets		Get a 7-Day Free Trial					0.39	1.51	3.02	0.53	0.05

Neurobiological Technologies Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09
Liabilities-to-Assets	Get a 7-Day Free Trial															0.56	0.75	0.73	0.05	0.02

Competitive Comparison of Neurobiological Technologies's Liabilities-to-Assets

For the Biotechnology subindustry, Neurobiological Technologies's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurobiological Technologies's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's Liabilities-to-Assets falls into.

Neurobiological Technologies Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Neurobiological Technologies's Liabilities-to-Assets Ratio for the fiscal year that ended in Jun. 2009 is calculated as:

Neurobiological Technologies's Liabilities-to-Assets Ratio for the quarter that ended in Sep. 2009 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurobiological Technologies  (OTCPK:NTII) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Neurobiological Technologies Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurobiological Technologies (Neurobiological Technologies) Business Description